ElectroMotive drug administration (EMDA) of Mitomycin C as first-line salvage therapy in high risk “BCG failure” non muscle invasive bladder cancer: 3 years follow-up outcomes

BACKGROUND: In case of high grade non-muscle invasive bladder cancer (HG-NMIBC), intravesical BCG represents the first-line treatment; despite the “gold” standard therapy, up to 50% of patients relapse, needing radical cystectomy. Hence, alternative therapeutic strategies have been developed. The ai...

Descripción completa

Detalles Bibliográficos
Autores principales: Racioppi, Marco, Di Gianfrancesco, Luca, Ragonese, Mauro, Palermo, Giuseppe, Sacco, Emilio, Bassi, Pier Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6282335/
https://www.ncbi.nlm.nih.gov/pubmed/30522445
http://dx.doi.org/10.1186/s12885-018-5134-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6282335/
https://www.ncbi.nlm.nih.gov/pubmed/30522445
http://dx.doi.org/10.1186/s12885-018-5134-7

Ejemplares similares